Table 3.
HSP extracellular vesicles in predictive and prognostic biomarker studies.
| HSPs | Disease type | Sample type | Findings | Reference |
|---|---|---|---|---|
| HSP70 | Carcinoma cells | Cell lines | Stimulate migration and cytolytic activity of natural killer cells | [51] |
| Breast cancer | Plasma samples | Higher in breast and lung cancers, compared with control groups | [118] | |
| Lung cancer | Plasma samples | Increase in metastatic lung cancer | [118] | |
| Human prostate carcinoma | Cell lines | Recognition of the tumor cells by the immune system | [165] | |
| Breast, lung, and ovarian cancer | Urine samples | HSP70 exosomes were higher in cancer patients than in healthy donors | [166] | |
|
| ||||
| HSP90 | Oral squamous cell carcinoma | Cell line | Lymph-node-metastatic | [26] |
|
| ||||
| HSP70 and HSP90 | Melanoma | Plasma from different disease stages | Disease progression and metastasis | [93] |
|
| ||||
| HSP72 | Thymoma, mammary carcinoma, and colon carcinoma | Mouse tumor cell lines | Stat3 activation (tumor survival mechanism and immunosuppressive function) | [87] |